Embody vs Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Embody and Hers are tied at 7.3/10. Embody is more affordable at $299/mo vs $348/mo. Choose Embody for users looking for the lowest entry price with round-the-cloc. Choose Hers for women who want glp-1 access from a well-known, publicly trad.
A side-by-side comparison of Embody and Hers covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#31 of 40Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.
Visit EmbodyHers
#33 of 40The women's health arm of Hims & Hers Health (NYSE: HIMS), offering compounded GLP-1 medications with a polished app experience designed for women's health needs.
Visit Hers| Feature | Embody | Hers |
|---|---|---|
| Our Score | 7.3/10 | 7.3/10 |
| Starting Price | $299/mo | $348/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Women who want GLP-1 access from a well-known, publicly traded telehealth brand |
| Ranking | #31 | #33 |
Pros & Cons Compared
Embody
Pros
- +$149 first month is one of the lowest entry prices in the GLP-1 market — includes medication, metabolic report, and 1:1 guidance
- +Oral tirzepatide gum format available — one of the few platforms offering a non-injectable tirzepatide option for needle-phobic patients
- +24/7 specialist support included at no extra cost for questions about dosing, side effects, and progress
- +Personalized metabolic report helps you understand your body's baseline before starting treatment
Cons
- −Monthly refill price jumps to $299/mo after the first month — nearly double what competitors like Mochi ($99/mo + membership) or TrimRx ($179/mo) charge
- −Compounded medications only — no brand-name Wegovy or Zepbound available through the platform
- −Limited company transparency — founding date, headquarters, and pharmacy partners are not publicly disclosed
Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Women-focused branding, content, and support — not a men's health platform with a women's tab
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Broader women's health platform — can address hormonal, skin, and wellness needs alongside weight loss
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Our Verdict
Embody and Hers are closely matched with identical scores of 7.3/10. If budget is your priority, Embody starts at $299/mo compared to Hers's $348/mo. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose Hers if you want: women who want glp-1 access from a well-known, publicly traded telehealth brand.